This content is machine translated Cochlear implants New insights at the interface of high-tech and sensory cells In Switzerland, around 5,000 people are currently fitted with cochlear implants – and the trend is rising, particularly in the over-65 age group, according to data from the Swiss Cochlear...…
View Post 6 min This content is machine translated Cannabis - medical vs. non-medical use Interim assessment: the boundaries are fluid Although it has been possible to obtain a prescription for cannabis medicines in Switzerland for a number of years, it is not uncommon for patients to incur considerably higher costs...…
View Post 6 min This content is machine translated Chronic insomnia, REM sleep instability and emotional dysregulation Risk factors for anxiety and depression With a prevalence of up to 10% in industrialized countries, chronic insomnia is one of the most common sleep disorders. Despite comparatively unremarkable objective sleep parameters, those affected report a...…
View Post 9 min This content is machine translated Dementia Recognize incipient progression and identify countermeasures The recommendations for the diagnosis and treatment of dementia published last year by the Swiss Memory Clinics (SMC) association are primarily aimed at primary care providers, emphasized Prof. Dr. med....…
View Post 6 min This content is machine translated Subtype-specific risks and implications for neurological care Suicidal tendencies in dementia Although dementia is primarily associated with cognitive and functional decline, clinical practice is increasingly showing an increased risk of suicidal thoughts, suicide attempts and suicide death rates. Differences in the...…
View Post 5 min This content is machine translated Pathogens in the brain When infections trigger strokes Infectious strokes are rarer than those caused by classic vascular risk factors, but play a significant role, particularly in resource-poor regions. Bacterial, viral, fungal and parasitic pathogens can directly damage...…
View Post 6 min This content is machine translated Prevalence, pathogenesis and individual treatment strategies Epilepsy in multiple sclerosis Epileptic seizures are one of the more frequently overlooked comorbidities in multiple sclerosis (MS). Recent studies have shown that the rate of epilepsy among MS patients is about twice as...…
View Post 14 min This content is machine translated Lung cancer Multidisciplinary teams in oncology The treatment of cancer is one of the greatest challenges of modern medicine. The complexity of oncological diagnostics and therapy, the multitude of treatment options available and the need to...… CME-Test
View Post 3 min This content is machine translated Therapy adherence and patient selection Injection fatigue in relapsing-remitting multiple sclerosis Injection fatigue and needle aversion are among the underestimated barriers in the treatment of patients with relapsing-remitting multiple sclerosis (RRMS). Current real-world analyses show a significantly lower persistence of injectable...…
View Post 5 min This content is machine translated Multiple sclerosis Unexpected side effects when switching from natalizumab to a biosimilar In May 2024, Imperial College Healthcare NHS Trust made extensive preparations to switch 80 patients with highly active, relapsing-remitting multiple sclerosis from an established monoclonal antibody drug to a biosimilar...…
View Post 12 min This content is machine translated Findings from the ALS Symposium 2024 in Montreal Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS) Amyotrophic lateral sclerosis (ALS) is a rapidly progressing, as yet incurable neurodegenerative disease that poses considerable medical, therapeutic and social challenges. Despite its comparatively low prevalence, ALS represents a central… CME-Test
